You are here: Home Newsroom Features Boots UK unveils findings from study into Antimicrobial Resistance in Long Term Care Facilities

Boots UK unveils findings from study into Antimicrobial Resistance in Long Term Care Facilities

17 April 2019
Feature Brand

 Findings are from largest dataset published to date across the UK

 

New UK-wide research, led by Boots UK has been published, looking into the use of antibiotics in care and residential homes (Long Term Care Facilities, LTCFs) across the UK. The research highlights the use of antibiotics in LTCFs and identifies potential gaps in knowledge and support for carers and residents when using antibiotics, with the aim of looking at how community pharmacy can provide additional support.

Antimicrobial resistance (AMR) is a major public health problem, causing patient safety issues for individual and health systems worldwide[1]. Residents in LTCFs are associated with higher rates of antibiotics use, particularly for urinary tract infections (UTIs)[2] which are frequently associated with antibiotic resistant organisms that can lead to treatment failure and blood stream infections. NHS improvement schemes in England currently focus on reducing inappropriate antibiotic prescribing by 50% by 2021, and improving the primary care management of UTIs to reduce the risk of E.coli blood stream infections[3].

A survey (point prevalence survey, PPS) was conducted by community pharmacists in November and December 2017 where data were collected for almost 18,000 residents across over 600 LTCFs in the UK. Whilst these results only provide a snapshot in time of antibiotic use within LTCFs, they are the largest dataset published to date across the UK[4].

The results of the PPS showed that more than two thirds (66.8%) of all LTCFs visited had a least one resident on antibiotics on the day of the visit.

Marc Donovan, Chief Pharmacist at Boots UK, said: “The results of this survey show there is a role for pharmacy teams working in collaboration within the LTCF environment to provide a greater focus on antimicrobial stewardship, supporting the national ambition to reduce inappropriate prescribing by 50% by 2021.

“This should include ongoing training and support for carers on self-care for residents, such as practical advice on how to support residents in taking antibiotics such as timings and dose form.”

The research paper, titled ‘Antimicrobial use in UK long-term care facilities: results of a point prevalence survey’, was co-authored by researchers at Boots UK, Public Health England and NHS Improvement.

It has been published in the Journal of Antimicrobial Chemotherapy (JAC). The full paper can be found here

 

[1] Infections globally: Final report and recommendations, the review on antimicrobial resistance, 2016. Welcome Trust. https://amrreview.org/sites/default/files/160525_Final%20paper_with%20cover.pdf

[2] Sundvall PD, Stuart B, Davis M et al. Antibiotic use in the care home setting: a retrospective cohort study analysing routine data. BMC Geriatrics 2015; 15:71

[3] Quality Premium. NHS England https://www.england.nhs.uk/ccg-out-tool/qual-prem/

[4] NHS National services Scotland. National Point Prevalence Survey of Healthcare Associated Infection and Antimicrobial Prescribing in Long Term Care Facilities, 2017. Health Protection Agency.   file://centre1/user/Home/T/tracey.thornley/Documents/Pharmacy%20Development/Research/Care%20homes/Audit%20data%20paper/Scottish%20PP%20survey%20care%20homes%202017.pdf

News

What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.

xx

Experts

Read the views of our team members at Boots, who are experts in their field. Find out what they think about the most important issues of the day – from healthcare equality to sustainability.

xx

Media Resources

A you are a journalist looking for information and resources about Boot? Visit our media resources hub to access images, reports, spokespeople and videos.

xx

Boots UK is the largest pharmacy-led health and beauty chain in the UK and its purpose is to champion everyone’s right to feel good. With 2,336* stores and a team of around 52,000* colleagues, of which approximately 6,600* are registered pharmacists, the Boots brand has been at the heart of local communities across the UK since 1849. Boots UK is committed to providing exceptional customer and patient care and being the first choice for pharmacy, beauty, healthcare and wellness, alongside offering its innovative portfolio of product brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle, Sleek MakeUP and YourGoodSkin.

Boots UK is part of Walgreens Boots Alliance (Nasdaq: WBA) – a global leader in retail pharmacy, impacting millions of lives every day through dispensing medicines, and providing accessible, high-quality care. More company information is available at boots-uk.com.

*As of Aug. 31, 2020